SLC40A1 and nervous system disorder: This study unravelled the intermolecular interaction of iron uptake at the blood-brain barrier, and provided potential therapeutic targets, such as astrocyte hepcidin and microvascular endothelial FPN1, for the treatment of brain iron dysregulation and its related neurological diseases.